VOYA Investment Management’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-26,772
Closed -$16.2K – 2522
2026
Q1
$16.2K Hold
26,772
– – ﹤0.01% 2339
2025
Q4
$25.7K Buy
26,772
+4,976
+23% +$7.05K ﹤0.01% 2390
2025
Q3
$37.9K Sell
21,796
-12,445
-36% -$24.4K ﹤0.01% 2405
2025
Q2
$71.6K Buy
34,241
+9,327
+37% +$17.9K ﹤0.01% 2548
2025
Q1
$42.5K Sell
24,914
-1,377
-5% -$5.17K ﹤0.01% 2569
2024
Q4
$133K Sell
26,291
-3,038
-10% -$15K ﹤0.01% 2506
2024
Q3
$160K Sell
29,329
-341
-1% -$2.25K ﹤0.01% 2545
2024
Q2
$142K Buy
29,670
+9,582
+48% +$49.9K ﹤0.01% 2578
2024
Q1
$62.5K Sell
20,088
-6,194
-24% -$20.8K ﹤0.01% 2705
2023
Q4
$74.6K Hold
26,282
– – ﹤0.01% 2802
2023
Q3
$77K Buy
26,282
+1,382
+6% +$4.57K ﹤0.01% 2789
2023
Q2
$71.2K Buy
24,900
+3,726
+18% +$13.4K ﹤0.01% 2866
2023
Q1
$65.4K Hold
21,174
– – ﹤0.01% 2761
2022
Q4
$44.7K Buy
+21,174
New +$64.3K ﹤0.01% 2861

Other funds holding HUMA

VOYA Investment Management's HUMA Position: Q2 2026 in Review

VOYA Investment Management sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 26,772 shares — an estimated $16.2K sold.

VOYA Investment Management first reported a position in HUMA in Q4 2022 and held it in 14 quarters. The position peaked at $160K in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • VOYA Investment Management reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • VOYA Investment Management sold 26,772 Humacyte shares in Q2 2026, an estimated $16.2K.
  • VOYA Investment Management first reported a position in Humacyte in Q4 2022 and held it in 14 quarters.
  • VOYA Investment Management's Humacyte position peaked at $160K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.